Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and ElectronicsBusiness Overview: ASE is a pharmaceutical health care companies, which through its group companies, manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and abroad
Ambalal Sarabhai Enterprises has announced the publication of its financial results for the quarter. The company has ensured that its standalone and consolidated unaudited financial statements have been widely disseminated through prominent English and Gujarati newspapers. This action aligns with the company's commitment to transparency, keeping all stakeholders, especially retail...
Ambalal Sarabhai Enterprises Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company has also published a notice for its 47th Annual General Meeting (AGM), including details on remote e-voting and e-voting during the AGM, along with the record date for dividend...
Ambalal Sarabhai Enterprises Limited has announced a confirmation from its Registrar and Transfer Agent, MCS Share Transfer Agent Limited, that all securities received for dematerialisation during the quarter ended have been processed, accepted or rejected, and listed on stock exchanges. The corresponding physical certificates have been mutilated and cancelled after...
Ambalal Sarabhai Enterprises Limited has announced a board meeting to consider the financial results for the quarter and half-year. The Board approved the audited consolidated and standalone financial results for the year ended March 31, 2025, with the statutory auditors providing an unqualified opinion. The company appointed M/s. RPSS &...
Ambalal Sarabhai Enterprises Limited has announced its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, issued by RPSS & Co., Practising Company Secretaries. The report confirms the company’s adherence to applicable statutory provisions, proper board processes, and compliance mechanisms. There were no new instances of non-compliance...
